Inflammatory Bowel Disease

Discussing the latest advances in Crohn’s disease and ulcerative colitis

Items Tagged ‘Humira’

February 10, 2017

FDA Approves Biosimilar to Humira

By Kanaaz Pereira kanaazpe

The FDA recently approved a biosimilar (trade name, Amjevita) to Humira (adalimumab). A biosimilar is a biological product that is highly similar to the originator drug, and has no clinical differences in terms of safety and effectiveness. Dr. Edward Loftus , M.D., talks about the potential of this drug to offer patients with chronic inflammatory diseases such as Crohn’s and ulcerative colitis an […]

View full entry

Tags: Amjevita, biosimilar, Crohn's disease, Edward Loftus, FDA, Humira, IBD, ulcerative colitis


March 26, 2016

Biologic Drugs – Are They Safe to Use During Pregnancy?

By Kanaaz Pereira kanaazpe

One of the major medical therapies used to treat chronic inflammatory conditions such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or psoriasis are anti-tumor necrosis factor (anti-TNF) agents. These include, but are not limited to drugs like Remicade, Simponi, Humira and Cimzia. Women who are pregnant, and taking these medications are always concerned about […]

View full entry

Tags: Anti-TNF agents, Cimzia, Clinical Gastroenterology and Hepatology, Crohn's disease, Humira, IBD, pregnancy, psoriasis, Remicade, rheumatoid arthritis, Simponi, Sunanda Kane


Contact Us · Privacy Policy